Mark Kimak

Mark Kimak is an experienced pharmaceutical professional with a robust background in sales and account management. Beginning a career at Sandoz Pharmaceuticals as a Sales Representative and progressing through various leadership roles, Mark excelled at driving sales and strategic planning, including a notable tenure as Regional Sales Director at Schering-Plough Pharmaceuticals, where annual sales revenues exceeded $250 million. At NOVARTIS PHARMACEUTICALS, Mark achieved national recognition as the Area of the Year award winner and successfully launched three top-ranking products. Mark's leadership in regional account management at Iroko Pharmaceutical involved launching a novel pain medication, while current roles at Sandoz Biopharmaceuticals and Fresenius Kabi USA focus on preparing and leading the market introduction of biosimilars. Mark holds an MBA in Management from Quinlan School of Business, Loyola University Chicago, and a Bachelor of Science in Marketing from Northern Illinois University.